Re: Human Papillomavirus and Oropharyngeal Cancer

* The new human papillomavirus vaccine (HPV) is recommended in a three-dose schedule with the second and third doses administered two and six months after the first dose. Routine vaccination with HPV is recommended for females aged 11-12 years; the vaccination series can be started in females as young as age 9 years; and a catch-up vaccination is recommended for females aged 13-26 years who have not been vaccinated previously or who have not completed the full vaccine series.

* The main change to the format of the schedule is the division of the recommendation into two schedules: one schedule for persons aged 0-6 years) and another for persons aged 7-18 years. Rota, HPV, and varicella vaccines are incorporated in the catch-up immunization schedule.